Support teaching, research, and patient care.
Infusions of Ketamine for management of complex regional pain syndrome and infusions of lidocaine for chronic pain syndromes.
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
This study is looking at the efficacy, durability, safety, and tolerability of multiple
single doses of Ketamine vs. active placebo for treating patients with treatment resistant
depression who are taking an antidepressant that is not working for them.
Stanford is currently not accepting patients for this trial.
For more information, please contact Jessica Hawkins, 650-723-8323.
View full details